In patients without diagnosed diabetes before renal transplantation, single nucleotide polymorphism (SNP) within angiotensinogen (AGT) (rs4762) seem to increase the risk of PTDM development in the dominant models (p = 0.03) after adjusting for age and tacrolimus usage, however, exact molecular mechanism of this relationship requires clarification [91]. This evidence concerns the gene AGT and diabetes mellitus.